Lapatinib

From Proteopedia

Revision as of 07:27, 6 December 2010 by David Canner (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

Pharmacokinetics

Glitazone Pharmacokinetics Comparison at Equivalent Dosages [1][2][3][4]
Parameter Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Tmax (hr) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Cmax (ng/ml) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Bioavailability (%) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Protein Binding (%) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
T1/2 (hr) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
AUC (ng/ml/hr) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
IC50 (nM) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Clearance (ml/hr) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Equivalent Dosage (mg) Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)
Metabolism Lapatinib (Tykerb) Sunitinib (Sutent) Sorafenib (Nexavar)

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Joel L. Sussman

Personal tools